Mupirocin lithium
REF : BP804
Descrição :Mupirocin lithium British Pharmacopoeia (BP) Reference Standard
Clique para mais informações
Clique para mais informações
Categoria : Selected Certified Reference Materials
Descrição detalhada : This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
Sinónimos : Lithium mupirocin; 9-((E)-4-{(2S,3R,4R,5S)-3,4-Dihydroxy-5-[(2S,3S)-3-((1S,2S)-2-hydroxy-1-methyl-propyl)oxiranylmethyl]tetrahydro-pyran-2-yl}-3-methyl-but-2-enoyloxy)nonanoic acid lithium salt; Pseudomonic acid A lithium salt
Fórmula molecula r: C26H43LiO9
Armazenamento : 2-8C
Embalagem : 1X1EA
Sinónimos : Lithium mupirocin; 9-((E)-4-{(2S,3R,4R,5S)-3,4-Dihydroxy-5-[(2S,3S)-3-((1S,2S)-2-hydroxy-1-methyl-propyl)oxiranylmethyl]tetrahydro-pyran-2-yl}-3-methyl-but-2-enoyloxy)nonanoic acid lithium salt; Pseudomonic acid A lithium salt
Fórmula molecula r: C26H43LiO9
Armazenamento : 2-8C
Embalagem : 1X1EA
